About AlphaNet

AlphaNet, Inc. is a not-for-profit health management company which provides a wide range of support services to individuals with Alpha-1. AlphaNet has created this program as a service to the Alpha-1 community and for the individuals, agencies and facilities that provide infusion services for them.

As the foundation of its health management program, AlphaNet created the Big Fat Reference Guide (BFRG), the most comprehensive guide to living with Alpha-1 to be found anywhere.

AlphaNet supports scientific research in Alpha-1. To date AlphaNet has donated over $58,000,000 to the Alpha-1 Foundation's research initiatives in search of a cure.

All personal information submitted as part of the Educational offering is protected by AlphaNet's Privacy Policy.

For additional information about AlphaNet return to the AlphaNet homepage at www.alphanet.org

About Alpha-1

Alpha-1 Antitrypsin Deficiency (Alpha-1) is one of the most common serious genetic disorders. It is believed that only 6,000 of the estimated 120,000 Americans with Alpha-1 have been diagnosed to date. An additional 21 million Americans are estimated to be genetic carriers of this order. Alpha-1 is associated with liver disease in children and severe liver and lung disease in adults, presenting as early emphysema and cirrhosis. Currently, the World Health Organization, the American Thoracic Society, and the European Respiratory Society recommend that all adults with the following conditions be tested for Alpha-1; COPD including chronic bronchitis and emphysema, chronic asthma, unexplained bronchiectasis, family history of Alpha-1 and chronic liver disease.